In addition, MTS, apoptosis, and cell cycle assays indicated the enhanced effects of USP22 overexpression and MDM2 inhibitor treatment in the inhibition of proliferation, and the induction of apoptosis and cell cycle arrest, in pancreatic cancer cells in vitro (Fig. 6C,D). This evidence concerns the gene USP22 and pancreatic neoplasm.